Cooper Companies (The) (COO) DIvidends Date & History

Key Takeaways

• The Cooper Companies, Inc. (COO) ended its de minimis semi-annual dividend program in December 2023.
• No dividend is currently paid, resulting in a yield of 0%.
• Previous annual dividend totaled $0.06 per share before termination.
• The company focuses on reinvesting in growth within contact lenses and surgical products.
• Dividend investors seeking income should look elsewhere; growth-oriented investors may find appeal in operations.
• Financial stability remains strong with no dividend obligation straining cash flows.

Dividend Overview

The Cooper Companies, Inc. (COO) does not currently pay a dividend. In December 2023, the board ended the company's prior de minimis semi-annual dividend of $0.03 per share. This program had delivered a negligible yield and was not positioned as a core return strategy. The firm operates in the medical instruments and supplies sector, emphasizing product development and acquisitions over shareholder distributions. Investors seeking regular income will not find it here, while those prioritizing capital appreciation may view the absence of payouts as supportive of long-term reinvestment.

Dividend History and Growth

Prior to termination, The Cooper Companies, Inc. (COO) maintained a consistent but minimal semi-annual dividend of $0.03 per share dating back several years. Payments occurred in January and August, with the final distribution in August 2023. There was no meaningful growth in the dividend amount over time, reflecting its symbolic rather than substantive role. The decision to discontinue the payout aligns with a strategic shift away from even small distributions toward funding expansion in CooperVision and CooperSurgical segments.

Dividend Sustainability and Payout Ratio

With no dividend in place, payout ratio and coverage metrics are not applicable. The prior tiny payout represented negligible strain on earnings or free cash flow. Ending the program further strengthens the balance sheet by preserving cash for operations and potential acquisitions. Debt levels and overall financial health support flexibility, though the company does not emphasize dividends as part of its capital allocation framework.

Dividend Compared to Industry Peers

Within the medical instruments and supplies sector, many peers maintain modest to moderate dividend programs with yields often ranging from 0.5% to 2%. Companies focused on healthcare equipment and devices frequently balance payouts with growth investments. The Cooper Companies, Inc. (COO) stands apart by offering zero yield post-termination, positioning it below average for income-focused investors but potentially competitive for those valuing full earnings retention.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.

Is This Stock Attractive for Dividend Investors?

The Cooper Companies, Inc. (COO) offers no current dividend, making it unsuitable for income-focused or conservative dividend investors who prioritize regular payouts and yield. Dividend growth investors seeking consistent increases will also find limited appeal given the program's termination. Long-term growth investors or those comfortable with zero yield may consider the stock for its operational strengths in eyecare and women's health products, where reinvested capital could drive future value. The absence of a dividend obligation supports financial flexibility but requires investors to rely solely on potential share price appreciation for returns. This profile suits those with a higher tolerance for non-income strategies within the healthcare sector.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations